Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction
Dennis M. Abraham, Teresa E. Lee, Lewis J. Watson, Lan Mao, Gurangad Chandok, Hong-Gang Wang, Stephan Frangakis, Geoffrey S. Pitt, Svati H. Shah, Matthew J. Wolf, Howard A. Rockman
Dennis M. Abraham, Teresa E. Lee, Lewis J. Watson, Lan Mao, Gurangad Chandok, Hong-Gang Wang, Stephan Frangakis, Geoffrey S. Pitt, Svati H. Shah, Matthew J. Wolf, Howard A. Rockman
View: Text | PDF
Research Article Cardiology Muscle biology

The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction

  • Text
  • PDF
Abstract

Cardiac two-pore domain potassium channels (K2P) exist in organisms from Drosophila to humans; however, their role in cardiac function is not known. We identified a K2P gene, CG8713 (sandman), in a Drosophila genetic screen and show that sandman is critical to cardiac function. Mice lacking an ortholog of sandman, TWIK-related potassium channel (TREK-1, also known Kcnk2), exhibit exaggerated pressure overload–induced concentric hypertrophy and alterations in fetal gene expression, yet retain preserved systolic and diastolic cardiac function. While cardiomyocyte-specific deletion of TREK-1 in response to in vivo pressure overload resulted in cardiac dysfunction, TREK-1 deletion in fibroblasts prevented deterioration in cardiac function. The absence of pressure overload–induced dysfunction in TREK-1–KO mice was associated with diminished cardiac fibrosis and reduced activation of JNK in cardiomyocytes and fibroblasts. These findings indicate a central role for cardiac fibroblast TREK-1 in the pathogenesis of pressure overload–induced cardiac dysfunction and serve as a conceptual basis for its inhibition as a potential therapy.

Authors

Dennis M. Abraham, Teresa E. Lee, Lewis J. Watson, Lan Mao, Gurangad Chandok, Hong-Gang Wang, Stephan Frangakis, Geoffrey S. Pitt, Svati H. Shah, Matthew J. Wolf, Howard A. Rockman

×

Figure 6

Fibroblast-specific TREK-1 loss of function protects against pressure overload–induced cardiac dysfunction.

Options: View larger image (or click on image) Download as PowerPoint
Fibroblast-specific TREK-1 loss of function protects against pressure ov...
(A) Conditional TREK-1 targeting strategy schematic: Frt sites flank a neomycin cassette and LoxP sites flank the conditional KO region. The conditional KO allele was obtained after Flp-mediated removal of the neomycin selection marker. (B) Serial echocardiographic measurements of average FS, (C) ESD, and (D) EDD in Kcnk2fl/fl alone (Cre negative), aMHC-cre;Kcnk2fl/fl (cardiomyocyte specific), and tcf21-iCre;Kcnk2fl/fl (fibroblast specific) mice up to 8 weeks after TAC. Error bars reflect SEM. Data were compared using 2-way repeated measures ANOVA. P values for the interaction between genotype and weeks after TAC are shown adjacent to brackets. Comparisons between genotypes at each time point were made using Bonferroni’s test for multiple comparisons. †P < 0.05 versus Kcnk2fl/fl; *P < 0.05 versus aMHC-cre;Kcnk2fl/fl. (E) Tissue fibrosis quantified after 12 weeks of TAC in Kcnk2fl/fl (sham = 3, TAC = 13 mice), aMHC-cre-cre;Kcnk2fl/fl (TAC = 5 mice), and tcf21-iCre;Kcnk2fl/fl (n = 9 mice) mice using Masson’s trichrome stain. (F) Representative histological sections showing fibrosis in purple. Comparisons between genotypes were made by Kruskal-Wallis test with uncorrected Dunn’s multiple comparisons test. *P < 0.05 versus Kcnk2fl/fl sham; †P < 0.05 versus Kcnk2fl/fl TAC; ‡P < 0.05 versus aMHC-cre;Kcnk2fl/fl.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts